Straathof
Adrianus Johannes Jozef Straathof, Delft NL
Patent application number | Description | Published |
---|---|---|
20120309918 | POLYPEPTIDES HAVING OXIDOREDUCTASE ACTIVITY AND THEIR USES - The invention relates to a polypeptide having oxidoreductase activity which comprises the amino acid sequence set out in SEQ ID NO: 3 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 4, or a variant polypeptide thereof having 45% or more sequence identity with the sequence of SEQ ID NO: 3. The invention also relates to a process for the production of 2,5-furan-dicarboxylic acid (FDCA) or production of 5-hydroxymethyl-2-furancarboxylic acid (HMF acid). | 12-06-2012 |
Adrianus Johannes Jozef Straathof, Lg Delft NL
Patent application number | Description | Published |
---|---|---|
20150112037 | PROCESS FOR THE PRODUCTION OF METHYL METHACRYLATE - The invention includes a process of producing methyl methacrylate or derivatives thereof is described. The process includes the steps of converting 2-butanone to methyl propionate using a Baeyer-Villiger monooxygenase, and treating the methyl propionate produced to obtain methyl methacrylate or derivatives thereof. A method of preparing polymers or copolymers of methyl methacrylate or its derivatives is also described. | 04-23-2015 |
Karin Straathof, London GB
Patent application number | Description | Published |
---|---|---|
20140086888 | EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE TREATMENT OF LOCOREGIONAL NASOPHARYNGEAL CARCINOMA (NPC) - The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV-specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMP1, and/or EBNA1, for example. | 03-27-2014 |